These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution. Chew KL, La MV, Lin RTP, Teo JWP. J Clin Microbiol; 2017 Sep; 55(9):2609-2616. PubMed ID: 28592552 [Abstract] [Full Text] [Related]
3. Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates. Galani I, Adamou P, Karaiskos I, Giamarellou H, Souli M. J Glob Antimicrob Resist; 2018 Dec; 15():123-126. PubMed ID: 30036693 [Abstract] [Full Text] [Related]
4. Polymyxin B Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICs. Kulengowski B, Ribes JA, Burgess DS. Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129 [Abstract] [Full Text] [Related]
6. Deciphering polymyxin B minimum inhibitory concentration from colistin minimum inhibitory concentration and vice versa: An analysis on 156 carbapenem-resistant Enterobacteriaceae isolates. Behera B, Jena J, Kar P, Mohanty S, Mahapatra A. Indian J Med Microbiol; 2018 Jan; 36(4):587-589. PubMed ID: 30880712 [Abstract] [Full Text] [Related]
9. A challenging case of carbapenem resistant Klebsiella pneumoniae-related pyogenic liver abscess with capsular polysaccharide hyperproduction: a case report. Sohrabi M, Pirbonyeh N, Alizade Naini M, Rasekhi A, Ayoub A, Hashemizadeh Z, Shahcheraghi F. BMC Infect Dis; 2024 Apr 23; 24(1):433. PubMed ID: 38654215 [Abstract] [Full Text] [Related]
10. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system. Perez LR. APMIS; 2015 Nov 23; 123(11):951-4. PubMed ID: 26361367 [Abstract] [Full Text] [Related]
14. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value. Oliva A, Scorzolini L, Cipolla A, Mascellino MT, Cancelli F, Castaldi D, D'Abramo A, D'Agostino C, Russo G, Ciardi MR, Mastroianni CM, Vullo V. J Antimicrob Chemother; 2017 Jul 01; 72(7):1981-1984. PubMed ID: 28369424 [Abstract] [Full Text] [Related]
16. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China. Chen X, Li P, Sun Z, Xu X, Jiang J, Su J. J Glob Antimicrob Resist; 2022 Sep 01; 30():357-362. PubMed ID: 35817263 [Abstract] [Full Text] [Related]
17. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil. Bartolleti F, Seco BM, Capuzzo Dos Santos C, Felipe CB, Lemo ME, Alves Tda S, Passadore LF, Mimica MJ, Sampaio SC, Zavascki AP, Sampaio JL. Emerg Infect Dis; 2016 Oct 01; 22(10):1849-51. PubMed ID: 27648951 [No Abstract] [Full Text] [Related]
18. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity? Cojutti P, Sartor A, Bassetti M, Scarparo C, Pea F. J Glob Antimicrob Resist; 2018 Sep 01; 14():238-241. PubMed ID: 29775786 [Abstract] [Full Text] [Related]